(Q33299647)

25 July 2017

Cerebrospinal fluid proteome profile in multiple sclerosis (English)

1 reference

25 July 2017

0 references

0 references

7

Tumani H

1 reference

25 July 2017

Lehmensiek V

1

1 reference

25 July 2017

Süssmuth SD

2

1 reference

25 July 2017

Tauscher G

3

1 reference

25 July 2017

Brettschneider J

4

1 reference

25 July 2017

Felk S

5

1 reference

25 July 2017

Gillardon F

6

1 reference

25 July 2017

1 August 2007

1 reference

Multiple Sclerosis Journal

25 July 2017

1 reference

25 July 2017

13

1 reference

25 July 2017

840-849

1 reference

25 July 2017

7

1 reference

Multiple sclerosis: MHC associations and therapeutic implications

25 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Proteomic analysis of multiple sclerosis cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Analysis of the human lumbar cerebrospinal fluid proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Clinical implications of the involvement of tPA in neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Tissue plasminogen activator gene expression in multiple sclerosis brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Transthyretin mutations in hyperthyroxinemia and amyloid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Transthyretin: a review from a structural perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Apolipoprotein E and multiple sclerosis: a biochemical and genetic investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Complement depletion suppresses Lewis rat experimental allergic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Clinical complementology: recent progress and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Structures of complement component C3 provide insights into the function and evolution of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Signal transduction and post-transcriptional gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

Apo E in multiple sclerosis and optic neuritis: the Apo E-o4 allele is associated with progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458507076406

21 January 2018

Identifiers

DOI

10.1177/1352458507076406

1 reference

25 July 2017

1 reference